Company: PIII
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001140361-25-016302
Chunk: 40

Company: P3 Health Partners Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 40
---
 granted in satisfaction of the second installment of transaction bonuses described in their transaction bonus agreements dated May 2022. |

| (3) | Amounts reflect the grant date fair value of the option awards granted to the named executive officers, as computed in accordance with FASB ASC Topic 718, but excluding any impact of estimated forfeiture rates as required by SEC regulations, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to calculate the value of all equity awards granted to executives in 2024 in Note 15 to the consolidated financial statements included in our 2024 Form 10-K. |

| (4) | Amounts represent bonuses earned by our NEOs under our annual bonus program. Please see the description of the annual bonus program under “2024 Bonuses” below. |

| (5) | In 2024, Dr. Coffman received cellphone reimbursement of $589; Dr. Abdou received severance pay of $1,046,154; Mr. Pedersen received cellphone reimbursement of $312; and Mr. Kavthekar received severance pay of $250,000, 401(k) matching contributions from the Company of $16,429 and cellphone reimbursement of $692. |

25

TABLE OF CONTENTS Narrative to Summary Compensation Table 2024 Salaries In 2024, the named executive officers received an annual base salary to compensate them for services rendered to our Company. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive’s skill set, experience, role and responsibilities. The 2024 annual base salaries for Dr. Coffman, Dr. Abdou, Dr. Bacchus, Mr. Pedersen and Mr. Kavthekar were $750,000, $800,000, $600,000, $440,000 and $500,000, respectively. 2024 Bonuses Our named executive officers were eligible to earn cash bonuses based upon the achievement of pre-established performance goals for 2024, including goals related to revenue, operating expense and Adjusted EBITDA achievement. The 2024 target bonus for Dr. Coffman was 75% of his annual base salary, for Drs. Abdou and Bacchus were 100% of their respective annual base salaries, for Mr. Pedersen was 50% of his annual base salary, and for Mr. Kavthekar was 75% of his annual base salary